In the Press/Publications
In the Press/Publications
April 2024
Loveday & Co
Loveday Abbey Road Enhances Care with VIVALDI
Loveday Abbey Road is delighted to participate in the VIVALDI Social Care pilot scheme, which was commissioned by the UK Health Security Agency during the pandemic to monitor infections in care homes.
August 2024
The Outstanding Society
Social Media Takeover
The VIVALDI Social Care Project is a national government-funded research project led by the Outstanding Society, Care England, and University College London. We are working together to tackle the problem of infection and outbreaks in care homes.
During the COVID-19 pandemic, people in care homes worked together with researchers and the Government to work out how to stop COVID-19. We want to build on what we learned in the pandemic to tackle infections and outbreaks, like flu and norovirus, which have a major negative impact on residents and their families. The first step to do this is to measure infections and outbreaks in each care home. The NHS already measures infection levels in hospitals, but no one measures infections in care homes.
Addressing these challenges requires innovative solutions, and one such approach is VIVALDI Social Care. This simple yet powerful strategy can lead to substantial improvements in how infections are handled and prevented in care homes not only having a positive impact on the people living in homes but people visiting and working in care homes.
By taking part, you can help us prevent and reduce infections, reports will be shared with care homes and policymakers so we can work out how to improve care.
Click here to listen to Stephen Fry explain the project during a short animation.
We are delighted to say we now have all ICBs with care home representation
Chris Day - CQC
Katie Thorn - Digital Care Hub
Diane & Kate - Rights for Residents
Rob Hargreaves- Skills for Care
February 2024
Journal of the American Medical Directors Association.
Built Environment and SARS-CoV-2 Transmission in Long Term Care Facilities: Cross Sectional Survey and Data Linkage
Authors: Krutikov M, Stirrup O, Fuller C, Altamirano H, Copas A, ... Shallcross L
January 2024
Dept Health & Social Care
Infection Prevention and Control (IPC) Champion Network Meeting
Chair: Charlotte Fry, RN, DN, QN, Expert Lead Nurse, IPC Champions Network
December 2023
Wellcome Open Research
VIVALDI Cohort Profile: Using linked, routinely collected data and longitudinal blood sampling to characterise COVID-19 infections, vaccinations, and related outcomes in care home staff and residents in England
Krutikov M, Bone D, Stirrup O, Bruton R, Azmi B, … Shallcross L
8th November 2023
Journal of Hospital Infection
COVID-19-related mortality and hospital admissions in the VIVALDI study cohort: October 2020 to March 2023
Stirrup O, Krutikov M, Azmi B, Monakhov I, Hayward A, Copas A, Shallcross L
January 2023
The Caring View – Podcast Channel
31st October 2023
Care Home Professional
New UK Health Security Agency scheme to target infections in care homes
30 October 2023
News Medical Life Sciences
UKHSA announces pilot scheme to monitor infections in care homes in England
24th October 2023
BMJ Open
Shaping care home COVID-19 testing policy: a protocol for a pragmatic cluster randomised controlled trial of asymptomatic testing compared with standard care in care home staff (VIVALDI-CT)
Adams N, Stirrup O, Blackstone J, Krutikov M, Cassell J, … Shallcross L
8th August 2023
Age and Ageing
Effectiveness of successive booster vaccine doses against SARS-CoV-2 related mortality in residents of long-term care facilities in the VIVALDI study
Stirrup O, Shrotri M, Adams N, Krutikov M, Azmi B, … Shallcross L
20th January 2023
Nature Aging
Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes
Tut G, Lancaster T, Krutikov M, Sylla P, Bone D, Spalkova E, ... Moss P
1st January 2023
Open Forum Infectious Diseases
Clinical effectiveness of SARS-CoV-2 booster vaccine against Omicron infection in residents and staff of Long-Term Care Facilities: a prospective cohort study (VIVALDI)
Stirrup O, Shrotri M, Adams N, Krutikov M, Nacer-Laidi H, Azmi B, ... & Shallcross L
1st July 2022
The Lancet Healthy Longevity
Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naïve residents of long-term care facilities: an observational cohort study
Tut, G., Lancaster, T., Butler, M., Bone, D., Kaur, N., Spalkova, E., ... & Moss, P
1st July 2022
The Lancet Healthy Longevity
Duration of vaccine effectiveness against SARS-CoV2 infection, hospitalisation, and death in residents and staff of Long-Term Care Facilities (VIVALDI): a prospective cohort study
Shrotri M, Krutikov M, Nacer-Laidi H, Azmi B, Palmer T, .. & Shallcross L
30th May 2022
Nature Aging
Robust SARS-CoV-2-specific and heterologous immune responses after natural infection in elderly residents of Long-Term Care Facilities
Tut G., Lancaster T., Butler M., Sylla P., Spalkova E., Bone D., ... & Moss P
16th April 2022
Journal of Infectious Diseases
SARS-CoV-2 anti-spike antibody levels following second dose of ChAdOx1 nCov-19 or BNT162b2 in residents of long-term care facilities in England (VIVALDI)
Stirrup, O., Krutikov, M., Tut, G., Palmer, T., Bone, D., Bruton, R., ... & Shallcross, L
1st March 2022
The Lancet Healthy Longevity
Outcomes of SARS-CoV-2 Omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study
Krutikov, M., Stirrup, O., Nacer-Laidi, H., Azmi, B., Fuller, C., Tut, G., ... & Shallcross, L
16th December 2021
The Lancet Healthy Longevity
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England
Krutikov M, Palmer T, Tut G, Fuller C, Azmi B, … Shallcross L
18th November 2021
Eurosurveillance
Changes in COVID-19 outbreak severity and duration in long-term care facilities following vaccine introduction, England, November 2020 to June 2021
Giddings R, Krutikov M, Palmer T, Fuller C, Azmi B, … Shallcross L
19th August 2021
The Lancet Healthy Longevity
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study
Tut G, Lancaster T, Krutikov M, Sylla P, Bone D, Kaur N, ... & Moss P
23rd June 2021
Lancet Infectious Diseases
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study
Shrotri M, Krutikov M, Palmer T, Giddings R, Azmi B, … Shallcross L
3rd June 2021
The Lancet Healthy Longevity
Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI study): a prospective cohort study
Krutikov, M., Palmer, T., Tut, G., Fuller, C., Shrotri, M., … Shallcross, L
29th April 2021
New England Journal of Medicine
Spread of a Variant SARS-CoV-2 in Long-Term Care Facilities in England
Krutikov M, Hayward A, Shallcross L
11th February 2021
Lancet Healthy Longevity
Factors associated with SARS-CoV-2 infection and outbreaks in long-term care facilities in England: a national cross-sectional survey.
Shallcross, L., Burke, D., Abbott, O., Donaldson, A., Hallatt, G., … Thorne, S
29th January 2021
Wellcome Open Research
Study Protocol: Understanding SARS-Cov-2 infection, immunity and its duration in care home residents and staff in England (VIVALDI)
Krutikov M, Palmer T, Donaldson A, Lorencatto F, Forbes G, … Shallcross L
3rd July 2020
Office for National Statistics